Merck quarterly profit up 18 percent
(Reuters) - Merck & Co Inc (NYSE:MRK - News) reported an 18 percent rise in quarterly profit, driven by higher sales of diabetes drug Januvia and heart drug Zetia.
Net income attributable to Merck rose to $1.12 billion, or 40 cents per share, in the first quarter, from $953 million, or 33 cents per share, a year earlier.
Revenue dipped about 1 percent to $9.31 billion.
(Reporting by Natalie Grover in Bengaluru; Editing by Savio D'Souza)